BVS
BVS
NASDAQ · Health Care

Bioventus Inc - A

$10.86
+0.00 (+0.00%)
As of Nov 14, 1:57 AM ET ·
Financial Highlights (FY 2026)
Revenue
681.80M
Net Income
27.29M
Gross Margin
68.3%
Profit Margin
4.0%
Rev Growth
+3.5%
D/E Ratio
1.65
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 68.3% 68.3% 45.6% 45.6%
Operating Margin 9.4% 8.5% 15.0% 14.8%
Profit Margin 4.0% 3.8% 14.9% 11.5%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 681.80M 658.61M 241.82M 197.18M
Gross Profit 465.87M 450.03M 110.34M 89.97M
Operating Income 64.36M 55.96M 36.38M 29.11M
Net Income 27.29M 23.72M 36.10M 22.67M
Gross Margin 68.3% 68.3% 45.6% 45.6%
Operating Margin 9.4% 8.5% 15.0% 14.8%
Profit Margin 4.0% 3.8% 14.9% 11.5%
Rev Growth +3.5% +3.5% -4.8% -2.4%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 279.57M 279.57M 254.88M 304.50M
Total Equity 169.54M 169.54M 321.56M 308.93M
D/E Ratio 1.65 1.65 0.79 0.99
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA 71.26M 65.40M 52.99M 46.00M
Free Cash Flow — — 25.01M 12.86M